Airway Medix will attract new investors. The company has restructured its debt
Airway Medix secured a EUR 900,000 loan with a potential investment of up to EUR 2 million within 18 months. An agreement with Discount Bank of Israel reduced the company's debt by more than 30 percent.
Warsaw, November 15, 2023: Airway Medix has completed negotiations with new partners, including CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group, obtaining financing for growth. It has received a EUR 900,000 loan, with a potential investment of up to EUR 2 million within 18 months. The partners will become operationally involved in the development and commercialisation of medical projects.
The agreement with Discount Bank of Israel Ltd. enabled a debt reduction of more than 30 percent, deferred debt repayment and secured the involvement of new investors.
Airway Medix is focused on innovative medical devices and the collaboration with the new partners is expected to accelerate product development and commercialisation.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Press releases are published as issued by Airway Medix S.A. Product statements follow the instructions for use.
